FibroGen

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$4.85-$21.93
Market Cap
$34.1M
Shares Short
135,894

Financials

See more
Revenue (12 Mos)
$8.2M
Revenue Growth (YoY)
774.8%
Gross Profit (12 Mos)
-$30.3M
Diluted EPS
-$12.85

News

See more

Yahoo Finance • 23 days ago

FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit

Yahoo Finance • last month

FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update

Yahoo Finance • 2 months ago

YieldBoost TGLS To 14.9% Using Options

Yahoo Finance • 3 months ago

FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer

About

CEO
Mr. Thane Wettig
CFO
Mr. David DeLucia
Address
350 Bay Street, San Francisco, CA, United States, 94133
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
225